SC 13G Filing

Company

bioAffinity Technologies, Inc.

Filed

October 10, 2023

Accession Number

0001493152-23-036597

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →